More M&A deals ahead for India's biotechs?; FDA accepts Pfizer NDA;

@FierceBiotech: BioSante soars on FDA nod for testosterone gel, regains some ground after failure of female libido gel. News | Follow @FierceBiotech

@JohnCFierce: Touting preclin results for a hep C treatment? A desperate cry for attention. BioCryst. Release | Follow @JohnCFierce

@RyanMFierce: UnitedHealth is planning a cloud-based platform, initially for healthcare users, but maybe pharma down the line: Article | Follow @RyanMFierce

@FierceMedDev: Post-Grateful Dead player scores medical hit. Story | Follow @FierceMedDev

> A new report on India's biotech sector concludes that lack of funding for drug developers will drive a larger number of M&A deals on the subcontinent. Story

> Pfizer ($PFE) reports the FDA has accepted its NDA on tafamidis meglumine, its oral therapy for the treatment of transthyretin familial amyloid polyneuropathy. Release

> Norway's Bionor says its final review of Phase IIb viral load data confirm a statistically significant reduction of HIV viral load on Vacc-4x versus placebo. Release

> The cancer research specialist Fahy Gurteen has moved into the Cambridge Research Park in the U.K. Story

Pharma News

@FiercePharma: Senator wants to attach drug-shortage measure to highway bill: 'Can't wait a year to get this done'--Reuters. Article | Follow @FiercePharma

> Merck gains traction in Brazil with joint venture. More

> GSK wraps up another 25,000 Avandia suits. Story

> FDA, Roche probe bogus Avastin found in U.S. News

Drug Delivery News

> Ensysce says carbon nanotubes delivered cancer drug. More

> Titan plans Q3 NDA submission for controlled-release implantable addiction treatment. Article

> Microscopic booms: China, U.S. efforts mull explosive use of nanotech drug delivery. News

> Can Medasys' new drug pump challenge Medtronic? Piece

> FDA biosimilar draft guidance creates drug delivery leeway. Story

Biomarkers News

> Positive results for biomarker based diagnostic CardioSCORE. News

> Collaborators work to create urine test for active TB. Item

> Gates Foundation funds TB biomarker research. Piece

> Progranulin biomarker predicts 5-year outcomes. Article

Medical Device News

> Does Riata recall indicate subpar device surveillance? Story

> Cayenne closes $10M to advance sports med portfolio. Item

> Stryker's Hartman sees salary boosted to $750K, MacMillan negotiates separation agreement. News

> Atossa files for IPO in effort to raise $6M. Report

> Quest to partner with Israeli biotech on MAP test. Article

And Finally... Swedish scientists have been working on new software that allows practitioners to use laser lights with drug combos to destroy cancer tumors. Release

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.